Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironment

被引：0
|
作者：
Natasha A. N. Jorge
Jéssica G. V. Cruz
Marco Antônio M. Pretti
Martín H. Bonamino
Patricia A. Possik
Mariana Boroni
机构：
[1] Brazilian National Cancer Institute,Bioinformatics and Computational Biology Lab, Division of Experimental and Translational Research
[2] Brazilian National Cancer Institute,Program of Immunology and Tumor Biology, Division of Experimental and Translational Research
[3] Fundação Oswaldo Cruz,Vice Presidency of Research and Biological Collections
来源：
Journal of Translational Medicine | / 18卷
关键词：
Metastatic melanoma; Tumor microenvironment; Immune evasion; miRNA; Tumor-TME crosstalk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Sulindac reverses an immunosuppressive tumor microenvironment associated with obesity-driven metastatic mammary tumors in mice
    McDonell, Shannon B.
    Cozzo, Alyssa J.
    Eisenbeis, Lydia K.
    Dannenberg, Andrew J.
    Hursting, Stephen D.
    CANCER RESEARCH, 2019, 79 (13)
  • [22] RNA NANOPARTICLE VACCINES OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT OF METASTATIC OSTEOSARCOMA
    Ligon, John
    Stover, Brian
    Mendez-Gomez, Hector
    Grippin, Adam
    Weidert, Frances
    Fagman, Lana
    Chardon-Robles, Jonathan
    Castillo, Paul
    Silver, Natalie
    Lagmay, Joanne
    Milner, Rowan
    Mitchell, Duane
    Sayour, Elias
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1444 - A1444
  • [23] Spatial organization of the tumour immune microenvironment (TIME) in primary and metastatic melanoma is associated with patient outcome
    Attrill, Grace Heloise
    Shteinman, Eva R.
    Bai, Xinyu
    Marsh-Wakefield, Felix
    Quek, Camelia
    Palendira, Umaimainthan
    Vergara, Ismael A.
    Long, Georgina V.
    Scolyer, Richard A.
    Wilmott, James S.
    CANCER RESEARCH, 2023, 83 (07)
  • [24] Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment
    Ghebremedhin, Anghesom
    Athavale, Dipti
    Zhang, Yanting
    Yao, Xiaodan
    Balch, Curt
    Song, Shumei
    CANCERS, 2024, 16 (19)
  • [25] Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
    Martinez-Morilla, Sandra
    Zugazagoitia, Jon
    Wong, Pok Fai
    Kluger, Harriet M.
    Rimm, David L.
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [26] Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome
    Tan, Lih Yin
    Mintoff, Chris
    Johan, M. Zahied
    Ebert, Brenton W.
    Fedele, Clare
    Zhang, You Fang
    Szeto, Pacman
    Sheppard, Karen E.
    McArthur, Grant A.
    Foster-Smith, Erwin
    Ruszkiewicz, Andrew
    Brown, Michael P.
    Bonder, Claudine S.
    Shackleton, Mark
    Ebert, Lisa M.
    ONCOTARGET, 2016, 7 (29) : 46492 - 46508
  • [27] Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment
    Sun, Belinda L.
    PROSTATE, 2021, 81 (15): : 1125 - 1134
  • [28] MicroRNA signature associated with poor outcome of glioblastoma patients
    Sana, Jiri
    Lakomy, Radek
    Fadrus, Pavel
    Smrcka, Martin
    Slampa, Pavel
    Kren, Leos
    Hermanova, Marketa
    Svoboda, Marek
    Slaby, Ondrej
    CANCER RESEARCH, 2014, 74 (19)
  • [29] MicroRNA SIGNATURE ASSOCIATED WITH POOR OUTCOME OF GLIOBLASTOMA PATIENTS
    Smrcka, Martin
    Sana, Jiri
    Lakomy, Radek
    Fadrus, Pavel
    Slampa, Pavel
    Kren, Leos
    Svoboda, Marek
    Hajduch, Marian
    Slaby, Ondrej
    NEURO-ONCOLOGY, 2014, 16
  • [30] Immunotype of Tumor Infiltrating Immune Cells and its Correlation with Clinical Outcome in Metastatic Melanoma
    Erdag, Gulsun
    Schaefer, Jochen T.
    Smolkin, Mark E.
    Patterson, James W.
    Petroni, Gina R.
    Slingluff, Craig L.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 882 - 882
12345